Arcosa Inc. (ACA)

Oscar Health is deeply undervalued but faces high short-term uncertainty due to ACA-specific risks and sector-wide negative catalysts. The expiration of ACA subsidies, adverse selection, and new legis...

Arcosa, Inc. (NYSE:ACA ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Antonio Carrillo - President, CEO & Director Erin Drabek - VP of Investor Relations Gail M. Pec...

Arcosa (ACA) Q2 EPS Jumps 40%

Arcosa (ACA) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.91 per share a year ago.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the second quarter...

Wind power surges as U.S. demand grows-stocks like DTE, BEP, ACA and D eye big gains amid tech-driven energy shifts.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the second ...

Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Arcosa (ACA) could produce exceptional returns because of its solid growth attributes.

The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Arcosa (ACA). While the effectiveness of this highly sought-after metric is questionable, the positive...